Effect of rose oil soft gel on controlling the symptoms of ulcerative colitis in comparison to placebo: a randomized double blind placebo controlled trial
Purpose : In this study, we compare rose oil soft gel with placebo in controlling the clinical symptoms of ulcerative colitis. Design of study and performance: This study is a randomized double blind placebo controlled trial in one center (Motahari Clinic)that perform On patients with ulcerative colitis that previously confirmed with colonoscopy , age> 18-70 years and at present have mild to moderate disease based on mayo clinic score. The main exclusion criteria are history of steroid use in the past 4 weeks, any NSAIDs in one week before, and the history of antibiotic use and any medicinal plants within 2 weeks before entering the study. 80 Samples select from target population that randomly assign at least 40 patients to each of two treatment arms. Patients randomly assign to receive either placebo(Sesame Oil soft gel) or rose oil soft gel, two capsule three times daily for two months with routine medications. Patients will be followed for 2 months. Patients will be visited 3 times, one at arrival and 2 times at the end of each month. Clinical symptoms and quality of life the patients will be evaluate with mayoclinic-6 standard form and IBDQ-9(Farsi version). The mayo clinic-6 standard form will be filled in at first visit and then weekly during 2 months of treatment by the patient, and IBDQ-9 will be filled in at the beginning of the study and after 2 months of treatment by the therapist. The CRP will be tested at beginning and end of the study. The primary outcome is control of clinical symptoms. possible side effects of medications will also record in the drug side effect registration questionnaire.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2016120323823N2
Registration date:2017-07-21, 1396/04/30
Registration timing:prospective
Last update:
Update count:0
Registration date
2017-07-21, 1396/04/30
Registrant information
Name
Ali Tavakoli
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 71 3233 1028
Email address
tavakkolia@sums.ac.ir
Recruitment status
Recruitment complete
Funding source
barijessence company and Shiraz University Of Medical Sciences
Expected recruitment start date
2017-07-23, 1396/05/01
Expected recruitment end date
2018-03-19, 1396/12/28
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of rose oil soft gel on controlling the symptoms of ulcerative colitis in comparison to placebo: a randomized double blind placebo controlled trial
Public title
Effect of rose oil soft gel on controlling the symptoms of ulcerative colitis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: patients with ulcerative colitis that previously confirmed with colonoscopy ;age> 18-70 years.
exclusion criteria: history of steroid use in the past 4 weeks; history of any NSAIDs use in one week before; history of antibiotic use within 2 weeks before entering the study; any medicinal plants within 2 weeks before entering the study.
Age
From 18 years old to 70 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
80
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Shiraz University Of Medical Sciences
Street address
Zand Strret
City
Shiraz
Postal code
Approval date
2016-03-06, 1394/12/16
Ethics committee reference number
IR.SUMS.REC.1394.211
Health conditions studied
1
Description of health condition studied
ulcerative colitis
ICD-10 code
K51
ICD-10 code description
Ulcerative colitis
Primary outcomes
1
Description
clinical symptoms
Timepoint
in at first visit and then weekly during 2 months of treatment
Method of measurement
mayo clinic-6 standard form
2
Description
quality of life
Timepoint
in at the beginning of the study and after 2 months of treatment
Method of measurement
IBDQ-9(Farsi version)
3
Description
CRP test
Timepoint
Before the intervention and end of the intervention(2 months)
Method of measurement
Device
4
Description
fecal calprotectin
Timepoint
Before the intervention and end of the intervention(2 months)
Method of measurement
stool exam
Secondary outcomes
1
Description
side effect
Timepoint
daily
Method of measurement
drug side effect registration questionnaire
Intervention groups
1
Description
80 Samples select from target population that assign at least 40 patients to each of two treatment arms.Patients in interventional group receive rose oil soft gel, two capsule three times. oral, daily, for two months.
Category
Treatment - Drugs
2
Description
Patients in control group receive placebo(Sesame Oil soft gel) two capsule three times,oral. daily for two months.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Motahari Clinic
Full name of responsible person
dr. Ali Tavakoli
Street address
Namazi Square,Zand Street
City
Shiraz
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Shiraz University Of Medical Sciences and barijessence company
Full name of responsible person
dr. Basir Hashemi
Street address
Zand Street
City
Shiraz
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shiraz University Of Medical Sciences and barijessence company
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty
Person responsible for general inquiries
Contact
Name of organization / entity
Shiraz University Of Mdical Sciences
Full name of responsible person
dr.Ali Tavakoli
Position
MD/phd student of traditional medicin
Other areas of specialty/work
Street address
Zand Street
City
Shiraz
Postal code
Phone
+98 71 3233 1028
Fax
Email
tavakkolia@sums.ac.ir
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
Shiraz University Of Medical Sciences
Full name of responsible person
dr.Mehdi Pasalar
Position
Research Center for Traditional Medicine and History of Medicine/phd of traditional medicine
Other areas of specialty/work
Street address
Zand Street
City
Shiraz
Postal code
Phone
+98 71 3233 7589
Fax
Email
pasalar@sums.ac.ir
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Shiraz University Of Medical Sciences
Full name of responsible person
dr. Ali Tavakoli
Position
MD/phd student of traditional medicien
Other areas of specialty/work
Street address
zand street
City
Shiraz
Postal code
Phone
+98 71 3233 1028
Fax
Email
tavakkolia@sums.ac.ir
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)